ArticleRheumatology international2025

Favorable outcomes for patients with refractory systemic lupus erythematosus treated with rituximab as evidenced with a follow-up of ≥ 10 years: a real-world evidence study.

Chrysanthi Staveri et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.